Geode Capital Management
ARIA

Geode Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Geode Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,534,851
Closed -$19.1M – 4134
2016
Q4 		$19.1M Buy
1,534,851
+44,008
+3% +$530K 0.01% 1118
2016
Q3 		$20.4M Buy
1,490,843
+169,641
+13% +$1.7M 0.01% 982
2016
Q2 		$9.76M Buy
1,321,202
+49,725
+4% +$373K 0.01% 1445
2016
Q1 		$8.12K Buy
1,271,477
+71,809
+6% +$402K ﹤0.01% 1535
2015
Q4 		$7.5M Buy
1,199,668
+12,145
+1% +$79.7K ﹤0.01% 1580
2015
Q3 		$6.93M Buy
1,187,523
+281
+0% +$2.17K ﹤0.01% 1605
2015
Q2 		$9.82M Buy
1,187,242
+56,477
+5% +$499K 0.01% 1428
2015
Q1 		$9.32M Buy
1,130,765
+88,751
+9% +$656K 0.01% 1442
2014
Q4 		$7.16M Buy
1,042,014
+11,203
+1% +$70.1K ﹤0.01% 1593
2014
Q3 		$5.57M Buy
1,030,811
+23,467
+2% +$137K ﹤0.01% 1695
2014
Q2 		$6.42M Buy
1,007,344
+108,640
+12% +$747K ﹤0.01% 1630
2014
Q1 		$7.24M Buy
898,704
+36,024
+4% +$281K ﹤0.01% 1480
2013
Q4 		$5.88M Buy
862,680
+60,517
+8% +$327K ﹤0.01% 1578
2013
Q3 		$14.8M Buy
802,163
+56,822
+8% +$1.1M 0.01% 840
2013
Q2 		$13M Buy
+745,341
New +$13.2M 0.01% 819

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Geode Capital Management's ARIA Position: Q1 2017 in Review

Geode Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,534,851 shares — an estimated $19.1M sold.

Geode Capital Management first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $20.4M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Geode Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Geode Capital Management sold 1,534,851 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $19.1M.
  • Geode Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Geode Capital Management's Ariad Pharmaceuticals Inc position peaked at $20.4M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Geode Capital Management's 13F filing for Q1 2017, filed 12 May 2017.